BRIEF-Immune Pharma announces initiation of enrollment in clinical trial with Ceplene

* Immune pharmaceuticals announces initiation of enrollment in clinical trial with ceplene®/ low-dose il-2 in chronic myelomonocytic leukemia (cmml)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.